CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Terbutalinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05326269
NCT05326269N/ACompleted
CompareCT.gov

Acute Tocolysis With Terbutaline vs Placebo Prior to Emergency Caesarean Delivery for Suspected Intrauterine Fetal Compromise

Hospital Kemaman·interventional·Posted Apr 13, 2022·Updated Apr 13, 2022

In Brief

A clinical study evaluating Terbutaline for Nonreassuring Fetal Status. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The trial was to determine the effect of administrating subcutaneous terbutaline prior to emergency caesarean delivery for suspected fetal distress

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNonreassuring Fetal Status
CountriesMalaysia
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedApr 13, 2022
Enrollment StartApr 23, 2017
Primary CompletionSep 15, 2019
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 4.2 years ago

Interventions

Terbutalinedrug

Subcutaneous injection